← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2013Last known activity
Nov 30, 2022
Timeline
2000s
- Jun 1, 2005
Aileron Therapeutics— Founded
2020s
- Oct 31, 2023
Lung Therapeutics, Inc— Acquired
Drugs by trial phase (9 distinct, 8 trials)
Phase 1 (5 own, 1 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (8)
- NCT05622058Lead sponsorPhase 1Nov 30, 2022
- NCT04022876Lead sponsorPhase 1/Phase 2Aug 31, 2019
- NCT02909972Study directorPhase 1Sep 1, 2016
- NCT02909972Lead sponsorPhase 1Sep 1, 2016
- NCT02264613Study directorPhase 1/Phase 2Oct 1, 2014
- NCT02264613Lead sponsorPhase 1/Phase 2Oct 1, 2014
- NCT01775358Study directorPhase 1Jan 1, 2013
- NCT01775358Lead sponsorPhase 1Jan 1, 2013
Details
- Founded
- Cambridge, MA, US Jun 1, 2005
- Last known activity
- Nov 30, 2022